On the Urban Debate, with Heena Gambhir, we discuss the permission to Bharat Biotech for intranasal booster dose trials in India that has been given by the Drugs Controller General of India (DCGI). The trials will be done at nine different sites. The Hyderabad-based manufacturer had proposed the booster dose for those who have been already been inoculated with Covishield and Covaxin vaccines. Bharat Biotech aims to conduct clinical trials on 5,000 healthy subjects: half or 2,500 individuals who have received Covishield and another 2,500 who have been administered Covaxin. Heena Gambhir lays down the bare facts before welcoming our guests for the night. We are joined by top experts, Dr Rajib Dasgupta, a member of the national COVID19 task force and Chandrakant Lahariya Health Systems Expert. Watch the full report to know more! #TheUrbanDebate #BoosterDose #HeenaGambhir
Posted from: 0001-01-01 00:00:00Z2022-01-28 17:39:00Z[]this blog via Microsoft Power Automate.
